Oral bioavailability property prediction based on task similarity transfer learning.

Journal: Molecular diversity
Published Date:

Abstract

Drug absorption significantly influences pharmacokinetics. Accurately predicting human oral bioavailability (HOB) is essential for optimizing drug candidates and improving clinical success rates. The traditional method based on experiment is a common way to obtain HOB, but the experimental method is time-consuming and costly. Recently, using AI models to predict ADMET properties has become a new and effective method. However, this method has some data dependence problems. To address this issue, we combine physicochemical properties with graph-based deep learning methods to improve HOB prediction, providing an efficient and interpretable alternative to traditional experimental and computational approaches for ADMET property studies in data-scarce scenarios. We propose a similarity-guided transfer learning framework, Task Similarity-guided Transfer Learning based on Molecular Graphs (TS-GTL), which includes a deep learning model, PGnT (pKa Graph-based Knowledge-driven Transformer). PGnT incorporates common molecular descriptors as external knowledge to guide molecular graph representation, leveraging GNNs and Transformer encoders to enhance feature extraction. Additionally, we introduce MoTSE to quantify the similarity between physicochemical properties and HOB. Notably, training with data pretrained model on logD properties showed the best performance in transfer learning. TS-GTL also outperformed machine learning algorithms and deep learning predictive tools, underscoring the critical role of task similarity in transfer learning.

Authors

  • Chen Zeng
    Department of Physics , The George Washington University , Washington , D.C. 20052 , United States.
  • Chengcheng Xu
    Intelligent Transportation Research Center, Southeast University, Nanjing, 210096, China. [email protected].
  • Yingxu Liu
    Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, China.
  • Yunya Jiang
    School of Science, China Pharmaceutical University, Nanjing 210009, PR China.
  • Lidan Zheng
    Laboratory of Molecular Design and Drug Discovery, School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, China.
  • Yang Liu
    Department of Computer Science, Hong Kong Baptist University, Hong Kong, China.
  • Yanmin Zhang
    Department of Paediatric Cardiology, Shaanxi Institute for Pediatric Diseases, Affiliate Children's Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Yadong Chen
    Laboratory of Molecular Design and Drug Discovery, School of Science, China; Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198 Jiangsu, China.
  • Haichun Liu
    Laboratory of Molecular Design and Drug Discovery, School of Science, China; Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198 Jiangsu, China.
  • Rui Gu
    Ethnic Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu 611131, China.

Keywords

No keywords available for this article.